- Home
- RDGT vs NLSP Comparison
RDGT vs NLSP Comparison
Compare RDGT & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDGT
- NLSP
- Stock Information
- Founded
- RDGT N/A
- NLSP 2015
- Country
- RDGT China
- NLSP Switzerland
- Employees
- RDGT N/A
- NLSP N/A
- Industry
- RDGT
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- RDGT
- NLSP Health Care
- Exchange
- RDGT NYSE
- NLSP Nasdaq
- Market Cap
- RDGT 5.7M
- NLSP 5.8M
- IPO Year
- RDGT N/A
- NLSP 2021
- Fundamental
- Price
- RDGT $0.96
- NLSP $2.30
- Analyst Decision
- RDGT
- NLSP
- Analyst Count
- RDGT 0
- NLSP 0
- Target Price
- RDGT N/A
- NLSP N/A
- AVG Volume (30 Days)
- RDGT 7.4K
- NLSP 423.9K
- Earning Date
- RDGT 07-29-2025
- NLSP 06-17-2025
- Dividend Yield
- RDGT N/A
- NLSP N/A
- EPS Growth
- RDGT N/A
- NLSP N/A
- EPS
- RDGT N/A
- NLSP N/A
- Revenue
- RDGT $147,126,392.00
- NLSP N/A
- Revenue This Year
- RDGT N/A
- NLSP N/A
- Revenue Next Year
- RDGT N/A
- NLSP N/A
- P/E Ratio
- RDGT N/A
- NLSP N/A
- Revenue Growth
- RDGT N/A
- NLSP N/A
- 52 Week Low
- RDGT $0.72
- NLSP $1.30
- 52 Week High
- RDGT $4.50
- NLSP $18.39
- Technical
- Relative Strength Index (RSI)
- RDGT N/A
- NLSP 65.15
- Support Level
- RDGT N/A
- NLSP $1.58
- Resistance Level
- RDGT N/A
- NLSP $2.39
- Average True Range (ATR)
- RDGT 0.00
- NLSP 0.23
- MACD
- RDGT 0.00
- NLSP 0.02
- Stochastic Oscillator
- RDGT 0.00
- NLSP 89.29
About RDGT RIDGETECH INC
Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.